Prevention of donor to recipient transmission of HCV in stem cell transplantation: some issues.
Dai
Chia-Yen
CY
Chuang
Wan-Long
WL
Huang
Jee-Fu
JF
Hsieh
Ming-Yen
MY
Yu
Ming-Lung
ML
D000998:Antiviral Agents / Q000008:administration & dosage*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006526:Hepatitis C / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*; D019562:Viral Load
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b